Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
56
GRX Quote, Financials, Valuation and Earnings
Last price:
$9.41
Seasonality move
:
-2.25%
Day range:
$9.38 - $9.43
52-week range:
$9.03 - $11.24
Dividend yield:
6.58%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
11.4K
Avg. volume:
22.7K
1-year change:
-5.23%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Gabelli Healthcare & WellnessRx Trust has -- downside to fair value with a price target of -- per share.
GRX vs. S&P 500
-
Over the past 5 trading days, Gabelli Healthcare & WellnessRx Trust has overperformed the S&P 500 by 0.04% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Gabelli Healthcare & WellnessRx Trust does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Gabelli Healthcare & WellnessRx Trust has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Gabelli Healthcare & WellnessRx Trust reported revenues of --.
Earnings Growth
-
Gabelli Healthcare & WellnessRx Trust has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Gabelli Healthcare & WellnessRx Trust reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2016-12-31 | 2017-12-31 | 2018-12-31 | 2019-12-31 | 2020-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $405.5K | $380.9K | $5.1M | |
| Total Assets | -- | -- | $272.3M | $307M | $286.5M | |
| Current Liabilities | -- | -- | $560.3K | $1.1M | $4M | |
| Total Liabilities | -- | -- | $688.3K | $1.3M | $44.3M | |
| Total Equity | -- | -- | $271.6M | $305.8M | $242.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-07-18 | 2024-07-18 | 2024-07-18 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
GRX
Sector
Market Cap
--
--
Price % of 52-Week High
83.9%
--
Dividend Yield
6.58%
--
Shareholder Yield
--
--
1-Year Price Total Return
-5.23%
--
Beta (5-Year)
0.995
--
Dividend yield:
6.58%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$9.43
200-day SMA
Sell
Level
$9.97
Bollinger Bands (100)
Sell
Level
9.39 - 9.91
Chaikin Money Flow
Sell
Level
-26K
20-day SMA
Sell
Level
$9.44
Relative Strength Index (RSI14)
Sell
Level
47.46
ADX Line
Sell
Level
25.44
Williams %R
Neutral
Level
-67.6026
50-day SMA
Sell
Level
$9.50
MACD (12, 26)
Buy
Level
2.57
25-day Aroon Oscillator
Sell
Level
-20
On Balance Volume
Sell
Level
-11K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Gabelli Healthcare & WellnessRx Trust operates as a diversified closed-end management investment company. The investment objective of the fund is the long-term growth of capital. The fund invests at least its assets in equity securities and income-producing securities of domestic and foreign companies in the healthcare and wellness industries. It invests in various sectors, of which Health Care Providers & Services, Food, Health Care Equipment and Supplies, and Pharmaceuticals account for the majority of the weightage.
Stock Forecast FAQ
In the current month, GRX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The GRX average analyst price target in the past 3 months is --.
-
Where Will Gabelli Healthcare & WellnessRx Trust Stock Be In 1 Year?
According to analysts, the consensus estimate is that Gabelli Healthcare & WellnessRx Trust share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Gabelli Healthcare & WellnessRx Trust?
Analysts are divided on their view about Gabelli Healthcare & WellnessRx Trust share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Gabelli Healthcare & WellnessRx Trust is a Sell and believe this share price will rise from its current level to --.
-
What Is Gabelli Healthcare & WellnessRx Trust's Price Target?
The price target for Gabelli Healthcare & WellnessRx Trust over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is GRX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Gabelli Healthcare & WellnessRx Trust is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of GRX?
You can purchase shares of Gabelli Healthcare & WellnessRx Trust via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Gabelli Healthcare & WellnessRx Trust shares.
-
What Is The Gabelli Healthcare & WellnessRx Trust Share Price Today?
Gabelli Healthcare & WellnessRx Trust was last trading at $9.41 per share. This represents the most recent stock quote for Gabelli Healthcare & WellnessRx Trust. Yesterday, Gabelli Healthcare & WellnessRx Trust closed at $9.43 per share.
-
How To Buy Gabelli Healthcare & WellnessRx Trust Stock Online?
In order to purchase Gabelli Healthcare & WellnessRx Trust stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
